Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.berh.2021.101660 http://scihub22266oqcxt.onion/10.1016/j.berh.2021.101660 33518410!7833276!33518410     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Best+Pract+Res+Clin+Rheumatol 2021 ; 35 (1): 101660 Nephropedia Template TP {{tp|p=33518410|t=2021. Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic |pdf=|usr=}}{{33518410}} gab.com Text Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic JO: Best Pract Res Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33518410 #FOAvip Laboratory evaluation of SARS-CoV-2 involves the detection of viral nucleic acid, viral protein antigens, and the antibody response. Molecular detection of SARS-CoV-2 is the only diagnostic test currently available in acutely or recently infected individuals. In contrast, serological testing is typically performed once viral RNA has been cleared and symptoms have resolved. This leads to some confusion among clinicians as to which test to order and when each is appropriate. While SARS-CoV-2 assays can suffer from poor sensitivity, all FDA authorized assays to date are intended to be qualitative. Serological tests have multiple assay formats, detect various classes of immunoglobulins, and have a distinct role in seroprevalence studies; however, the association with long-term protection remains unclear. Both molecular and serological testing for SARS-CoV-2 have complementary roles in patient management, and we highlight the challenges faced by clinicians and laboratorians alike in the evaluation and interpretation of the currently available laboratory assays. Twit Text FOAVip Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic ????Best Pract Res Clin Rheumatol http://www.kidney.de/pget.php?&tw=1&pmid=33518410 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33518410 #FOAvip English Wikipedia <ref>{{Cite pmid|33518410}}</ref> Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic #MMPMID33518410 Parikh BA; Farnsworth CW Best Pract Res Clin Rheumatol 2021[Mar]; 35 (1): 101660 PMID33518410show ga Laboratory evaluation of SARS-CoV-2 involves the detection of viral nucleic acid, viral protein antigens, and the antibody response. Molecular detection of SARS-CoV-2 is the only diagnostic test currently available in acutely or recently infected individuals. In contrast, serological testing is typically performed once viral RNA has been cleared and symptoms have resolved. This leads to some confusion among clinicians as to which test to order and when each is appropriate. While SARS-CoV-2 assays can suffer from poor sensitivity, all FDA authorized assays to date are intended to be qualitative. Serological tests have multiple assay formats, detect various classes of immunoglobulins, and have a distinct role in seroprevalence studies; however, the association with long-term protection remains unclear. Both molecular and serological testing for SARS-CoV-2 have complementary roles in patient management, and we highlight the challenges faced by clinicians and laboratorians alike in the evaluation and interpretation of the currently available laboratory assays. |*COVID-19[MESH] |*Pandemics[MESH] |Humans[MESH] |Laboratories[MESH] |SARS-CoV-2[MESH] |Sensitivity and Specificity[MESH]Laboratory evaluation of SARS-CoV-2 in the COVID-19 pandemic (epmc).pdf DeepDyve Pubget Overpricing